One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report.
Saved in:
| Title: | One-Year Real-World Outcomes of Switching to Aflibercept 8 mg in Eyes with Neovascular Age-Related Macular Degeneration: A Swiss Retina Research Network Report. |
|---|---|
| Authors: | Kitay, Alice M.1 (AUTHOR), Tillmann, Anne2 (AUTHOR), Pfister, Isabel3 (AUTHOR), Schild, Christin3 (AUTHOR), Bonanata, Matteo4 (AUTHOR), Heck, Katharina5 (AUTHOR), Spitznagel, Tahm6,7 (AUTHOR), Gabathuler, Felix8 (AUTHOR), Bartolomeo, Nicolo9 (AUTHOR), Magnin, Simon10 (AUTHOR), Löliger, Jordan11 (AUTHOR), Munk, Marion R.2,12,13 (AUTHOR), Menghini, Moreno4 (AUTHOR), Hatz, Katja5 (AUTHOR), Somfai, Gábor Márk6,7,14 (AUTHOR), Zweifel, Sandrine8 (AUTHOR), Ambresin, Aude9 (AUTHOR), Eandi, Chiara M.10,15 (AUTHOR), Feltgen, Nicolas11 (AUTHOR), Weinberger, Andreas16 (AUTHOR) |
| Source: | Ophthalmology & Therapy. Apr2026, Vol. 15 Issue 4, p1375-1388. 14p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
